Micromodule Discussion Series: Incorporating New Regimens for Optimal Management of Early-Stage and Advanced NSCLC
The treatment of all stages of non-small cell lung cancer (NSCLC) continues to evolve, particularly in the early stages as immunotherapy moves into the perioperative setting. This initiative includes an interactive infographic of latest updates in the treatment of NSCLC with supporting case-based micromodules, in which expert faculty share their insights into their clinical practice for the management of early-stage and advanced NSCLC.
Join Heather Wakelee, Jonathan Spicer, and Karen Reckamp as they share their insights and experiences through a case-based micromodule discussion series. Review an interactive infographic for an in-depth look at the latest clinical trial data across the spectrum of NSCLC.
This initiative is provided by Paradigm Medical Communications, LLC.